TNF Receptors and Kidney Health in Chronic Kidney Disease
Author Information
Author(s): Per Wändell, Tobias Feldreich, Anders Larsson, Philip A. Kalra, Johan Ärnlöv, Toralph Ruge, Axel C. Carlsson
Primary Institution: Karolinska Institutet
Hypothesis
Are higher levels of TNF receptors associated with increased mortality and kidney function decline in chronic kidney disease patients?
Conclusion
Higher levels of TNFR2 are linked to increased mortality, while TNFR1 does not show a significant association with mortality or kidney function decline.
Supporting Evidence
- Higher TNFR2 levels were significantly associated with increased mortality risk.
- TNFR1 showed borderline significance for mortality but was not statistically significant after adjustments.
- Neither TNFR1 nor TNFR2 predicted decline in kidney function when adjusted for baseline eGFR.
Takeaway
This study found that a protein called TNFR2 can help predict if kidney disease patients might die sooner, but TNFR1 isn't as helpful.
Methodology
The study analyzed patients with chronic kidney disease stages 3-5, measuring TNFR levels and their association with mortality and kidney function decline using regression models.
Potential Biases
The study may have bias due to the exclusion of patients on dialysis and limited demographic diversity.
Limitations
The study's findings may not be generalizable due to the cohort being primarily White and referred patients with advanced CKD.
Participant Demographics
The cohort consisted mainly of White patients with chronic kidney disease, with 97% being White and only 3% non-White.
Statistical Information
P-Value
p<0.05
Confidence Interval
1.03–1.34 for TNFR2
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website